Saturday, February 2, 2019

Hepatitis C - Generic DAAs achieve excellent cure rates in Egypt

Source: infohep
Treatment Outcomes

Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost
Michael Carter / 01 February 2019
Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved...


On This Blog
Controversy and barriers over hepatitis C drugs
Link to news articles addressing barriers to hepatitis C treatment, for instance insurance restrictions of these therapies by private insurers Medicare or Medicaid. In addition review research articles on the effectiveness, safety and availability of generic versions of hepatitis C medications.

No comments:

Post a Comment